Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity.

MLA

Christopoulos, Petros, et al. “Radiation-Free Allogeneic Conditioning with Fludarabine, Carmustine, and Thiotepa for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies Necessitating Enhanced Central Nervous System Activity.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 18, no. 9, Sept. 2012, pp. 1430–37. EBSCOhost, https://doi.org/10.1016/j.bbmt.2012.02.016.

APA

Christopoulos, P., Bertz, H., Ihorst, G., Marks, R., Wäsch, R., & Finke, J. (2012). Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 18(9), 1430–1437. https://doi.org/10.1016/j.bbmt.2012.02.016

Chicago

Christopoulos, Petros, Hartmut Bertz, Gabriele Ihorst, Reinhard Marks, Ralph Wäsch, and Jürgen Finke. 2012. “Radiation-Free Allogeneic Conditioning with Fludarabine, Carmustine, and Thiotepa for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies Necessitating Enhanced Central Nervous System Activity.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 18 (9): 1430–37. doi:10.1016/j.bbmt.2012.02.016.